PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2147087
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2147087
The global spirometer market size was valued at USD 815.6 million in 2025. The market is projected to grow from USD 892.9 million in 2026 to USD 1,675.2 million by 2034, exhibiting a CAGR of 8.2% during 2026-2034. North America dominated the global market with a 43.91% share in 2025, supported by strong respiratory disease screening, advanced healthcare infrastructure, and growing adoption of connected diagnostic devices.
A spirometer is used to measure the volume and flow of air inhaled and exhaled from the lungs. These devices are widely used for diagnosing and monitoring asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders. Growing disease prevalence, rising pulmonary screening, clinical trial adoption, and technological improvements in portable and home-use spirometers are supporting market expansion.
Spirometer Market Trends
A major market trend is the shift toward remote and home-based spirometry. Portable and connected devices allow patients to measure parameters such as FEV1, FVC, FEV1/FVC ratio, and peak expiratory flow from home. Data can be transmitted through Bluetooth, mobile applications, cloud platforms, and remote patient monitoring systems.
In January 2024, NuvoAir Medical received U.S. FDA 510(k) clearance for the Air Next Spirometer for in-home use, supporting wider adoption of decentralized respiratory monitoring.
Market Drivers
The key market driver is the increasing adoption of portable, handheld, connected, and home-use spirometers. Manufacturers are integrating wireless connectivity, cloud platforms, AI-assisted interpretation, calibration-free functionality, and digital reporting into newer devices.
In May 2026, Medical International Research S.p.A. partnered with Locus Health to integrate spirometry technology into the Locus Health remote patient monitoring platform.
The growing respiratory disease burden is also supporting demand. According to WHO statistics cited in the report, approximately 363 million people globally were affected by asthma in 2023.
Market Restraints and Challenges
The high cost of advanced respiratory testing systems can limit adoption. Advanced equipment may include spirometry, lung-volume measurement, DLCO testing, body plethysmography, software, calibration systems, and EMR/EHR integration. The MIR Spirolab Spirometer, for instance, was reported to cost around USD 3,100-3,500.
Connected spirometers also create regulatory, cybersecurity, privacy, and software-validation challenges. Increased use of cloud platforms and remote data transmission requires manufacturers to comply with stringent healthcare data protection requirements.
Market Opportunities
The expansion of healthcare infrastructure in developing countries creates significant opportunities. Rising investments in hospitals, primary care centers, diagnostic laboratories, and telehealth networks are increasing the number of locations capable of providing lung-function testing.
India's PM-ABHIM program, for example, allocated approximately USD 7.4 billion toward strengthening healthcare infrastructure according to 2025 government data cited in the report.
By product type, the devices segment dominated in 2025, supported by technological advancements and continued product innovation. The software segment is projected to grow at a CAGR of 8.4%.
By type, volume measurement devices held the largest share in 2025, while peak flow meters are projected to grow at a CAGR of 8.7%.
By application, the COPD segment dominated with a 44.7% share in 2025. The asthma segment is projected to grow at a 7.8% CAGR.
By end user, hospitals dominated in 2025 and are expected to account for 39.0% of the market in 2026. Diagnostic centers are forecast to grow at an 8.0% CAGR.
North America led the market with a value of USD 358.2 million in 2025. The U.S. market is estimated at around USD 345.5 million in 2026.
Europe is projected to reach USD 205.4 million in 2026, with Germany at approximately USD 37.8 million and the U.K. at USD 36.0 million.
Asia Pacific is estimated to reach USD 217.6 million in 2026. China is projected at USD 59.9 million, Japan at USD 51.8 million, and India at USD 23.8 million.
Latin America is expected to reach USD 44.6 million in 2026, while the GCC market is estimated at USD 16.4 million.
Competitive Landscape
Major companies include ndd Medizintechnik, COSMED, MGC Diagnostics, Vitalograph, Chest M.I., Jaeger Medical, Ganshorn Medizin Electronic, Medical International Research, and Midmark Corporation. Companies are focusing on product certifications, connected devices, software platforms, acquisitions, and advanced respiratory diagnostics.
Key Industry Developments
In December 2025, COSMED acquired Ergometrix. In November 2025, MGC Diagnostics launched the Meridian Series. In December 2024, Ganshorn received U.S. FDA approval for its PowerCube+ series, while ndd Medical Technologies launched EasyOne Sky in November 2024.
Conclusion
The spirometer market is expected to expand from USD 815.6 million in 2025 to USD 892.9 million in 2026 and USD 1,675.2 million by 2034, at a CAGR of 8.2% during 2026-2034. Growth will be driven by rising respiratory disease prevalence, connected and home-use spirometry, healthcare infrastructure expansion, and technological advancement. However, high equipment costs and data-security requirements may restrain adoption. North America is expected to remain the leading regional market, while Asia Pacific is likely to gain momentum as respiratory diagnostic access expands.
Segmentation By Product Type, Type, Application, End User, and Region
By Product Type
By Type
By Application
By End User
By Region